- MedAffairs Leaders Forum
- Speaker List
- Event Structure
- MedAffairs: Strategy & Capabilities
- MedAffairs: Real-World Evidence
- MedAffairs: Communications & Liaison
- MedAffairs: Effectivness for Small Pharma & Medtech
- MedAffairs: Persuasion & Influence Skills
- Event Partners
- Related Videos
- View Agenda or Register
Event Overview
This 3-day forum is the “must attend” event for those senior decision-makers looking to drive their medical affairs teams and departments and enhance their KOL & stakeholder engagement at all levels.
Speakers List
LARGE & MEDIUM PHARMA
Vice President Development and Chief Medical Officer
Abbvie, USA
Senior Vice President, Head of Medical Affairs EMEA
Astellas Pharma, UK
Vice President, North America Medical Affairs Hospital Business
Pfizer Biopharmaceuticals Group
Global Medical Director Endocrine & IEM
Pfizer Rare Disease, Belgium
Global Head, Real World Evidence Strategy
Biogen
SMA Program Lead/ Medical Research Operations/ MERI (Medical Evidence, Research, and Innovation)
Biogen, Switzerland
Global Medical Director, Therapeutic Area Head, CNS & Pain
Abbott, Switzerland
EMEA Medical Lead Neurology & Immunology
Merck Group, Belgium
Regional Director, Medical Science Liaisons
Novartis, USA
Director, Global Medical Excellence
Allergan, USA
SMALLER PHARMA, BIOTECH & MEDTECH
Medical Affairs Oncology Director EMEA
Kyowa Kirin, UK
Head of Hearing Science and Clinical Research
MED-EL Medical Electronics, Austria
Director, Medical Scientific Liaison, EMEA
Alimera Sciences, UK
Regulatory Affairs & Drug Safety Director
Dompé Pharmaceuticals, Italy
Regulatory Affairs Manager Biotech & Hi-tech
Dompé Pharmaceuticals, Italy
Senior Director, Medical Affairs & Operations
Voyager Therapeutics, USA
EXTERNAL STAKEHOLDERS
Member, Committee for Advanced Therapies
European Medicines Agency
Senior Scientific Adviser – IMI Get Real
Science Policy and Research
National Institute for Health and Care Excellence (NICE), UK
Head of the Cardiology Department
University Hospital of Geneva, Switzerland
Patient Representative & Inclusion Advocate Chair: Access Matters, Midstream,
Board Member; European Forum for Good Clinical Practice (EFGCP), Healthcare Quality Improvement Partnership (HQIP), International Foundation for Integrated Care (IFIC)
CEO
The Synergist - Patient Focused Medicine, Belgium
Program Manager
The Synergist - Patient Focused Medicine, Belgium
CEO
Patient View, UK
TECHNOLOGY COMPANIES
Customer Engineer - Government & Healthcare
Google Cloud, UK
EXPERIENCED SOLUTION PROVIDER
Account Director
OPEN Health Medical Communications, UK
Managing Director
Within3
Media
CEO & Founder
PharmaPhorum, UK
Event Structure
Photo Gallery
Event Overview
MedAffairs: Strategy & Capabilities
Stream Overview
The first day will feature several keynote presentations from VP-Level thought leaders on shaping and leading the medical affairs departments, justifying medical affairs performance through innovative metrics and tracking effectiveness of the function as an essential element of today’s pharmaceutical companies. They will be discussing the strategic drivers for medical affairs, and guidance on how to make best use of this vital function.
Speakers
Vice President Development and Chief Medical Officer
Abbvie, USA
Vice President, North America Medical Affairs Hospital Business
Pfizer Biopharmaceuticals Group
Global Medical Director, Therapeutic Area Head, CNS & Pain
Abbott, Switzerland
EMEA Medical Lead Neurology & Immunology
Merck Group, Belgium
Patient Representative & Inclusion Advocate Chair: Access Matters, Midstream,
Board Member; European Forum for Good Clinical Practice (EFGCP), Healthcare Quality Improvement Partnership (HQIP), International Foundation for Integrated Care (IFIC)
CEO
The Synergist - Patient Focused Medicine, Belgium
Account Director
OPEN Health Medical Communications, UK
Managing Director
Within3
MedAffairs: Real-World Evidence
Stream Overview
Generating real world evidence via observational studies and the use of patient registries is one of the fastest growing areas of pharmaceutical R&D. Such post-marketing studies are becoming increasingly important as regulatory agencies demand more long-term data which demonstrates efficacy, safety and quality. The Medical Affairs unit plays a decisive role in generating this vital evidence and this stream will present solutions to the challenges companies face in generating high-quality evidence which will communicate a compelling value argument to all necessary stakeholders.
Speakers
Global Medical Director Endocrine & IEM
Pfizer Rare Disease, Belgium
Global Head, Real World Evidence Strategy
Biogen
SMA Program Lead/ Medical Research Operations/ MERI (Medical Evidence, Research, and Innovation)
Biogen, Switzerland
Regulatory Affairs & Drug Safety Director
Dompé Pharmaceuticals, Italy
Member, Committee for Advanced Therapies
European Medicines Agency
Senior Scientific Adviser – IMI Get Real
Science Policy and Research
National Institute for Health and Care Excellence (NICE), UK
Customer Engineer - Government & Healthcare
Google Cloud, UK
MedAffairs: Communications & Liaison
Stream Overview
Medical Affairs departments are increasingly looking to implement next generation medical communication practices, to offer essential evidence-based information to stakeholders on demand, through a variety of classical, yet also increasingly digital channels. This stream will focus on two key aspects of medical communication. Firstly, issues such as: protocol writing for internal late-phase studies and research initiatives; working with External Experts (KOLs) to enhance publications, abstracts & posters and receiving proposals for investigator-initiated studies. The second section of this day will focus on Medical Scientific Marketing communications, including the review process, compliance issues, ensuring the claims made by marketing colleagues are justified and appropriately communicated and also effectively localized from global-level to country-level market requirements. The day will also feature best practice case studies on structuring, managing, and monitoring the evolving Medical Science Liaison role within your organisation. This meeting is an ideal chance to benchmark with other market leaders in this field who are utilising the unique MSL function to more effectively communicate with external experts, engage them with advanced science and demonstrate product evidence. All attending will discovery how MSLs can help regain the credibility of the pharmaceutical industry as a value-adding partner to the healthcare ecosystem.
Speakers
Regional Director, Medical Science Liaisons
Novartis, USA
Director, Global Medical Excellence
Allergan, USA
Director, Medical Scientific Liaison, EMEA
Alimera Sciences, UK
Head of the Cardiology Department
University Hospital of Geneva, Switzerland
Program Manager
The Synergist - Patient Focused Medicine, Belgium
CEO
Patient View, UK
MedAffairs: Effectivness for Small Pharma & Medtech
Stream Overview
- Building an effective, medical affairs team with limited resources, that adds-value to external stakeholders
- Determining what capabilities, skills, resources and team structure is realistically required to maximise performance
- Cultural change: Transformation to a patient and stakeholder-centric organization, that is science-led
- Maximisation of real-world evidence generation on limited budgets
- Leveraging both classical and digital medical communication strategies with a small team to maximise dialogue with KOLs and stakeholders
- Demonstrating the value of medical affairs to internal stakeholders
Speakers
Medical Affairs Oncology Director EMEA
Kyowa Kirin, UK
Head of Hearing Science and Clinical Research
MED-EL Medical Electronics, Austria
Regulatory Affairs Manager Biotech & Hi-tech
Dompé Pharmaceuticals, Italy
Senior Director, Medical Affairs & Operations
Voyager Therapeutics, USA
MedAffairs: Persuasion & Influence Skills
Stream Overview
Who are your trainers?
Geoff Cable
CEO & co-Founder
NextLevel Life Sciences
Luke Rogers
CEO & co-Founder
NextLevel Life Sciences
"We believe that sales isn't a job, it's a life skill"
Geoff and Luke are experts in soft skills, negotiation, business development, management & entrepreneurship. They have a strong track record of growing their successful company organically, through sales and marketing. Both are Australians and also CEOs and co-founders of NextLevel Life Sciences, a leading event organiser and business intelligence provider for the Biopharma and Medtech industries. Over the last 12 years, Luke and Geoff have developed, promoted and delivered hundreds of industry events, focused on cutting-edge or critical themes. These have involved thousands of senior-level attendees from all the major pharma, medtech, biotech and diagnostics companies, as well as a broad range of service providers and key industry stakeholders. NextLevel Life Sciences has a strong value proposition, an effective process, but especially a customer-centric sales philosophy.
This event will enable you to:
1) Understand how medical affairs are at the forefront of new pharmaceutical industry commercial models and what needs to be done to maximise success.
2) Discover which are the most intelligent ways to map and engage with KOLs and other prescribers, payers, patient groups, pharmacies and tomorrow’s stakeholders.
3) Measure the performance of your medical affairs team and individuals.
4) Benchmark with experts to find out the best practices in late phase research, especially observational studies, patient registries and investigator-initiated studies.
5) Discover how medical scientific liaisons, in support of commercial teams, are crucial to the communication of effectiveness, safety and cost effectiveness.
6) Get real-life experiences of medical affairs capabilities development in smaller Pharma, Biotech & MedTech companies.
PHARMA & MEDICAL DEVICE: VPs, Directors & Managers of:
Customer Relations, Medical Affairs, Medical Science Liaisons, Medical Education, Health Outcomes & Liaison, Medical Communications, Marketing, KOL & Stakeholder Engagement, Late Phase & Real-World Research, Scientific Affairs, Medical Advisors and Patient-Centricity.
Event Partners
This event is accredited for CPD (Continuing Professional Development) status
RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH
Event Venue
Previous Attendees at MedAffairs Leaders Forum - Zurich, Switzerland, 2019
EVENT TESTIMONIALS
"Highly recommended for both starters in Medical Affairs and more experienced Medical Affairs colleagues to learn about new developments in Excellence and taking Leadership in Medical Affairs roles"
Head Medical Affairs, Global Medical and Scientific Affairs CPS
Roche Diagnostics
“The MedAffairs Leaders Forum brought together managers from pharma/biotech and representatives from patient organizations, regulators, and service providers. In a professional, yet informal setting, valuable insights and best practices shared. Anticipating future trends was highly inspirational facilitating innovative thinking. I took important learnings, ideas, and contacts from the meeting allowing me to put new approaches into practice.”
Senior Manager, Medical Communications,
Amgen
Related Videos
Presentation
Biopharmaceutical Acceleration Model for product development and commercialization
- Meeting the needs of health system stakeholders demanding both clinical and real-world evidence to inform decisions regarding product use and reimbursement
- Case study: The benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs
Speaker
Mike D’Ambrosio
Senior Project Director, Real World & Late Phase
Syneos Health, UK
Presentation
Leveraging online discussion platforms for optimal KOL & Physician engagement
- Identify the logistical and resource barriers to domestic and global KOL engagement
- Which solutions can enable Pharma & MedTech to better engage & generate valuable insights from KOLs & External Experts
- Improving KOL engagement outcomes while maintaining regulatory compliance
Speakers
Pauline De Mari
Vaccines Innovative Medical Engagement Lead
Sanofi
Andy Bowman
Managing Director
Within3